Showing 181 - 200 results of 489 for search '(( greater decrease ) OR ((((( liver increase ) OR ( master decrease ))) OR ( line decrease ))))', query time: 0.10s Refine Results
  1. 181

    Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets by Adviti Naik (673163)

    Published 2022
    “…More specifically, they show that silencing of overall SSX expression reduces tumor growth and completely inhibits metastatic burden of lung and liver in vivo. Molecularly, they found that SSX silencing induces cell cycle stalling, increased apoptosis and reduced migration and invasion potential of melanoma cells. …”
  2. 182
  3. 183

    Unsustainability in emergent systems by Haddad, Marc

    Published 2017
    “…In this paper we present a detailed case study of the passenger road transport system in the Greater Beirut Area (GBA) where we identify the root causes of the major problems facing the system today and over the long-term. …”
    Get full text
    Get full text
    Get full text
    Get full text
    conferenceObject
  4. 184
  5. 185
  6. 186
  7. 187

    Severe Cholestatic Hepatitis caused by Thiazolidinediones by Azar, Riad

    Published 2002
    “…Clinical evaluation and liver biopsy were performed and liver function tests were monitored. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    Use of acid suppressive therapy in hospitalized non-critically ill patients by Sheikh-Taha, Marwan

    Published 2012
    “…CONCLUSION: AST is overused in hospitalized non-critically ill patients and many patients are discharged on unnecessary AST which can increase cost, drug interactions and adverse events. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  14. 194

    Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy by Afsheen Raza (492657)

    Published 2022
    “…We propose that combination therapy to increase the efficacy of NY-ESO-1 specific immunotherapeutic interventions should be explored to unleash the immune response against NY-ESO-1 expressing tumors.…”
  15. 195

    Oxandrolone in Pediatric Patients with Severe Thermal Burn Injury by Btaiche, Imad F.

    Published 2008
    “…Based on clinical studies, oxandrolone 0.1 mg/kg twice daily is safe when given for up to 12 months. However, mild increases in serum liver transaminase concentrations and reversible sexual changes were observed during therapy. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200